Dalton Pharma Services has completed a $5 million expansion in sterile filling and API manufacturing at its cGMP facility in Toronto, Canada. The project added three new sterile processing suites and an active pharmaceutical ingredient (API) manufacturing suite, and included the addition of a semi-automated powder filling line with significant scale-up of lyophilization capacity. Also included were increased analytical capabilities, increased chemistry capacity, and facility upgrades to meet ...